Results 161 to 170 of about 242,932 (337)
Percutaneous mechanical circulatory support for acute right heart failure: A practical approach
ESC Heart Failure, EarlyView.This is an overview of percutaneous mechanical circulatory support options for acute right heart failure, illustrating key clinical scenarios, device types, and principles of tailored device selection based on haemodynamics and underlying pathology. Abstract Acute right heart failure (RHF) represents a critical entity with significant morbidity and ...
Mario Gramegna +18 more
wiley +1 more source
ESC Heart Failure, EarlyView.Among 668 with cardiogenic shock included in the multicentre prospective Altshock‐2 registry, 299 patients (44.8%) received pre‐admission beta‐blocker therapy. Previous beta‐blocker therapy influenced the early hemodynamic response to vasoactive drugs, but it was not associated with in‐hospital mortality.
Matteo Pagnesi +21 more
wiley +1 more source
The Effect of Norepinephrine on the 5-Hydroxytryptophan Decarboxylase Activity of Rat Kidney
, 1959 James A. Buzard, Priscilla D. Nytch
openalex +1 more source
The Effects of Anesthetics on the Release of Norepinephrine from Sympathetic Nerves [PDF]
, 1968 H.K. Ngai +2 more
openalex +1 more source
Clinical phenotyping of cardiogenic shock at a glance: A rapid, costless, streamlined approach
ESC Heart Failure, EarlyView.Abstract Aims Cardiogenic shock (CS) is a heterogeneous syndrome in which recent guidelines have proposed clinical phenotyping based on the presence of hypoperfusion and/or congestion signs and symptoms. However, the impact of this clinical phenotype on outcomes remains poorly characterized.
Miloud Cherbi +5 more
wiley +1 more source
Cardiac Norepinephrine Stores in Experimental Heart Failure in the Dog* [PDF]
, 1964 Charles A. Chidsey +4 more
openalex +1 more source
Calorigenic Effect of Norepinephrine Correlated with Plasma Free Fatty Acid Turnover and Oxidation* [PDF]
, 1964 Daniel Steinberg +3 more
openalex +1 more source
ESC Heart Failure, EarlyView.Temporary RVAD support following HM3 LVAD is associated with high morbidity and mortality. Temporary RVAD support occurs most frequently in INTERMACS 1 or 2 patients and those who require pre‐operative VA‐ECMO. In addition to higher post‐operative mortality, a significantly higher risk of both dialysis and stroke at 1 year post‐implant was observed in ...
Vinh Q. Chau +12 more
wiley +1 more source